|Contract Type:||Permanent, full-time|
|Education:||Master in public health, biology, pharmacy or other life sciences. Postgraduate degree in the field would be an asset.|
|Experience:||No previous experience required|
|Compensation:||According to qualifications and experience|
The employee is expected to participate in Health Economics and Outcomes Research (HEOR) projects for clients across multiple therapeutic and geographic markets. You will be working in the evidence synthesis team, on systematic literature reviews relating to clinical, health economic and outcomes research studies. You will be involved at all the steps of the projects; your tasks and responsibilities will include:
Development strategies for literature reviews (search strategies, protocol report)
Carry out the study selection (screening)
Critical appraisal of clinical, health economic and outcomes research studies
Writing the review reports and develop slide kit
Participate in internal initiatives e.g. attend or prepare internal presentations on relevant topics
You will be working under the supervision a senior analyst on all projects and you will be provided with required training.
If you are looking to develop expertise in scientific consulting, in a young and dynamic environment, please send your CV and a cover letter explaining your motivations at: firstname.lastname@example.org.
Applications will only be accepted in English.
Master in public health, biology, pharmacy or other life sciences. Postgraduate degree in the field would be an asset;
Good communication skills, including presentations and report writing;
Good knowledge in Microsoft Office e.g. Word, PowerPoint and Excel;
Ability to synthetize complex information;
Good attention to detail and ability to meet high quality standards;
Ability to adapt, work in a team and independently;
Creativ-Ceutical is an international consulting firm dedicated to supporting the life science industry and health authorities in strategic decision making. We provide professional market access and pricing services that combine strong technical know-how with real strategic expertise. From our start in 2008 we have grown to more than 60 employees and a partner network across Europe, North America and Asia.
We have broad experience in the therapeutic areas of central nervous system (CNS), vaccine-preventable diseases, respiratory, metabolic disorders and oncology. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other therapeutic domains.